R. Sidhu

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

J.-Y. Douillard, Salvatore Siena, J Cassidy et al. · Annals of Oncology · 2014 · 604 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

Marc Peeters, Timothy Price, Andrés Cervantes et al. · Annals of Oncology · 2013 · 220 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Faecal lactoferrin – a novel test to differentiate between the irritable and inflamed bowel?

R. Sidhu, Peter W.F. Wilson, Andrew Wright et al. · Alimentary Pharmacology & Therapeutics · 2010 · 57 citations

Life Sciences, Immunology, Inflammation +16

Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E–mutated (BRAFm) metastatic colorectal cancer (mCRC)

Ryan B. Corcoran, Thierry André, Takayuki Yoshino et al. · Annals of Oncology · 2016 · 46 citations

Medicine, Oncology, Pharmacology +17

Low rates of serious complications but high rates of hardware removal after high tibial osteotomy with Tomofix locking plate

R. Sidhu, Gilbert Moatshe, Andrew Firth et al. · Knee Surgery Sports Traumatology Arthroscopy · 2020 · 42 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +7